We are pleased to present the scope of the journal...
With a 2015 impact factor of 6.399 Neuropsychopharmacology ranks 12th of 140 Psychiatry journals, 11th of 253 Pharmacology and Pharmacy journals, and 21st of 256 Neuroscience journals. 97% of accepted articles are published online in less than 25 business days and in print in less than 88 business days. In 2015, all issues of Neuropsychopharmacology were published on or ahead of schedule.
Online readership spiked in 2013 with almost 2.1 million page views, almost 1,057,000 site visits, and over 1.5 million article views. The site averaged 2,896 visits per day and 57% of the page views were from outside the US. More than 100,000 individuals registered for NPP's electronic table of contents alerts, making it more subscribed to than Nature Neuroscience.
Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses upon clinical and basic science contributions that advance our understanding of the brain and behavior, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. While original reports are preferred, mini-reviews and perspectives are invited by the editorial office.
In view of the interdisciplinary nature of the field, particular emphasis is placed on:
studies that advance the biological bases of normal and pathological behavior
the nature, etiology and pathophysiology of neuropsychiatric disorders
biologically relevant aspects of the epidemiology, diagnosis, and treatment of these disorders
the basic mechanisms by which psychopharmacological agents exert their effect
Dr William A Carlezon Jr, PhD
Instructions for Authors:
Instructions for Reviewers:
Are you receiving Neuropsychopharmacology e-alerts?